Skip to content

The effect of different sedative drugs on sepsis induced liver injury in ICU

The effect of different sedative drugs on sepsis induced liver injury in ICU

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101418
Enrollment
Unknown
Registered
2025-04-24
Start date
2022-06-04
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Test group:Sedation using Remazolam
Control group:Sedation using Propofol or Midazolam

Sponsors

The First Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meets the Sepsis 3.0 diagnostic criteria: confirmed or suspected infection, with an increase in the SOFA score by =2 points from baseline. 2. Age >=18 years. 3. The patient or their legal guardian has signed the informed consent form related to this study.

Exclusion criteria

Exclusion criteria: 1. Pregnant women and cancer patients. 2. Acute or chronic hepatitis. 3. Liver cirrhosis. 4. Chronic renal insufficiency requiring maintenance hemodialysis. 5. Other conditions deemed unsuitable for inclusion by the physician.

Design outcomes

Primary

MeasureTime frame
Time to achieve the goal of sedation;dose of sedative required to reach target sedation;time to awakening after drug discontinuation;

Secondary

MeasureTime frame
total dose of remifentanil used for analgesia;Duration of invasive mechanical ventilation;ICU mortality rate; ICU length of stay;liver function indicators;

Countries

China

Contacts

Public ContactLi Bin

The First Hospital of Lanzhou University

lynd001@163.com+86 931 835 6960

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026